# Feasibility of Transvenous Phrenic Nerve Stimulation for Diaphragm Protection in Acute Respiratory Failure

> **NCT05465083** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 20 (actual)

## Conditions studied

- Acute Hypoxemic Respiratory Failure
- Diaphragm Injury
- Lung Injury

## Interventions

- **DEVICE:** Lungpacer AeroPace Protect System

## Key facts

- **NCT ID:** NCT05465083
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-04
- **Primary completion:** 2023-10-15
- **Final completion:** 2023-11-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05465083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05465083, "Feasibility of Transvenous Phrenic Nerve Stimulation for Diaphragm Protection in Acute Respiratory Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05465083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*